EASL Studio Podcast S4 E12: NAFLD and NASH – moving beyond the liver biopsy – where are we now?

EASL Studio Podcast S4 E11: YI Choice: Gene therapy for liver disease — RNA interference and beyond

EASL Studio Podcast S4 E10: Ascites: New solution for an old problem?

EASL Studio Podcast S4 E9: YI Choice: Gender equality in academics — reducing the gap

EASL Studio Podcast S4 E8: Alcohol and food policies

EASL Studio Podcast S4 E7: Genetics in adult liver disease – missed opportunities?

EASL Studio Podcast S4 E6: Regenerating the liver graft with a machine?

EASL Studio Podcast S4 E5: AI for Dummies

EASL Studio Podcast S4 E4: JHEP Live: Is the term ‘decompensated cirrhosis’ outdated?

EASL Studio Podcast S4 E3: A 360 approach to beat alcohol-related liver disease

EASL Studio Podcast S4 E2: YI Choice: How to build consortia and registries

EASL Studio Podcast S4 E1: Hepatitis B elimination: How far behind are we and what do we need to change to achieve it?

EASL Studio Podcast S3 E16: Liver cancer in 2022: Wrap-up & outlook

EASL Studio Podcast S3 E15: Chronic portal vein thrombosis: Anticoagulation and interventional radiology for all patients?

EASL Studio Podcast S3 E14: The future of hepatology

EASL Studio Podcast S3 E13: Next-generation metrics for science beyond journal impact factor and citations: The role of social media

EASL Studio Podcast S3 E12: Meeting the challenge of antimicrobial resistance (AMR) in cirrhosis: the invisible threat that lies within

EASL Studio Podcast S3 E11: Regenerative Hepatology: From stem cells to tissue engineering

EASL Studio Podcast S3 E10: Cholestatic pruritus: Can the itch be ditched?

EASL Studio Podcast S3 E9: JHEP Live: Antisense oligonucleotides vs. siRNAs in the treatment of chronic hepatitis B: Who will be the winner, if at all?